23 research outputs found
Novel parent-of-origin-specific differentially methylated loci on chromosome 16
BACKGROUND: Congenital malformations associated with maternal uniparental disomy of chromosome 16, upd(16)mat, resemble those observed in newborns with the lethal developmental lung disease, alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV). Interestingly, ACDMPV-causative deletions, involving FOXF1 or its lung-specific upstream enhancer at 16q24.1, arise almost exclusively on the maternally inherited chromosome 16. Given the phenotypic similarities between upd(16)mat and ACDMPV, together with parental allelic bias in ACDMPV, we hypothesized that there may be unknown imprinted loci mapping to chromosome 16 that become functionally unmasked by chromosomal structural variants.
RESULTS: To identify parent-of-origin biased DNA methylation, we performed high-resolution bisulfite sequencing of chromosome 16 on peripheral blood and cultured skin fibroblasts from individuals with maternal or paternal upd(16) as well as lung tissue from patients with ACDMPV-causative 16q24.1 deletions and a normal control. We identified 22 differentially methylated regions (DMRs) with ≥ 5 consecutive CpG methylation sites and varying tissue-specificity, including the known DMRs associated with the established imprinted gene ZNF597 and DMRs supporting maternal methylation of PRR25, thought to be paternally expressed in lymphoblastoid cells. Lastly, we found evidence of paternal methylation on 16q24.1 near LINC01082 mapping to the FOXF1 enhancer.
CONCLUSIONS: Using high-resolution bisulfite sequencing to evaluate DNA methylation across chromosome 16, we found evidence for novel candidate imprinted loci on chromosome 16 that would not be evident in array-based assays and could contribute to the birth defects observed in patients with upd(16)mat or in ACDMPV
Differences in the composition of the bacterial element of the urinary tract microbiome in patients undergoing dialysis and patients after kidney transplantation
IntroductionThe development of molecular biology methods and their application in microbial research allowed the detection of many new pathogens that cause urinary tract infections (UTIs). Despite the advances of using new research techniques, the etiopathogenesis of UTIs, especially in patients undergoing dialysis and patients after kidney transplantation, is still not fully understood.MethodsThis study aimed to characterize and compare the composition of the bacterial element of the urinary tract microbiome between the groups of patients undergoing dialysis (n = 50) and patients after kidney transplantation (n = 50), with positive or negative urine culture, compared to healthy individuals (n = 50).ResultsAsymptomatic bacteriuria was observed in 30% of the urine cultures of patients undergoing dialysis and patients after kidney transplantation, with Escherichia coli as the most dominant microorganism (73%) detected with the use of classical microbiology techniques. However, differences in the bacterial composition of the urine samples between the evaluated patient groups were demonstrated using the amplicon sequencing. Finegoldia, Leptotrichia, and Corynebacterium were found to be discriminative bacteria genera in patients after dialysis and kidney transplantation compared to the control group. In addition, in all of urine samples, including those without bacteriuria in classical urine culture, many types of bacteria have been identified using 16S rRNA sequencing.DiscussionThe revealed microbial characteristics may form the basis in searching for new diagnostic markers in treatment of patients undergoing dialysis and patients after kidney transplantation
PhaseDancer: a novel targeted assembler of segmental duplications unravels the complexity of the human chromosome 2 fusion going from 48 to 46 chromosomes in hominin evolution
Abstract Resolving complex genomic regions rich in segmental duplications (SDs) is challenging due to the high error rate of long-read sequencing. Here, we describe a targeted approach with a novel genome assembler PhaseDancer that extends SD-rich regions of interest iteratively. We validate its robustness and efficiency using a golden-standard set of human BAC clones and in silico-generated SDs with predefined evolutionary scenarios. PhaseDancer enables extension of the incomplete complex SD-rich subtelomeric regions of Great Ape chromosomes orthologous to the human chromosome 2 (HSA2) fusion site, informing a model of HSA2 formation and unravelling the evolution of human and Great Ape genomes
A de novo 2.2 Mb recurrent 17q23.1q23.2 deletion unmasks novel putative regulatory non-coding SNVs associated with lethal lung hypoplasia and pulmonary hypertension : a case report
BACKGROUND : Application of whole genome sequencing (WGS) enables identification of non-coding variants that
play a phenotype-modifying role and are undetectable by exome sequencing. Recently, non-coding regulatory
single nucleotide variants (SNVs) have been reported in patients with lethal lung developmental disorders (LLDDs)
or congenital scoliosis with recurrent copy-number variant (CNV) deletions at 17q23.1q23.2 or 16p11.2, respectively.
CASE PRESENTATION : Here, we report a deceased newborn with pulmonary hypertension and pulmonary interstitial
emphysema with features suggestive of pulmonary hypoplasia, resulting in respiratory failure and neonatal death
soon after birth. Using the array comparative genomic hybridization and WGS, two heterozygous recurrent CNV
deletions: ~ 2.2 Mb on 17q23.1q23.2, involving TBX4, and ~ 600 kb on 16p11.2, involving TBX6, that both arose de
novo on maternal chromosomes were identified. In the predicted lung-specific enhancer upstream to TBX4, we
have detected seven novel putative regulatory non-coding SNVs that were absent in 13 control individuals with the
overlapping deletions but without any structural lung anomalies.
CONCLUSIONS : Our findings further support a recently reported model of complex compound inheritance of LLDD in
which both non-coding and coding heterozygous TBX4 variants contribute to the lung phenotype. In addition, this
is the first report of a patient with combined de novo heterozygous recurrent 17q23.1q23.2 and 16p11.2 CNV
deletions.Additional file 1. Schematic representation of 16p11.2 copy-number
variant (CNV) deletion region. A) The 16p11.2 CNV region (hg19) depicting
the identified deletion in the presented patient with pulmonary hypoplasia.
The genes mapping within the deletion and complex low-copy
repeats flanking the recurrent deletion are shown. B) Alignment tracks
showing whole genome sequencing coverage at 16p11.2 CNV region in
the father, mother, and child (upper, middle, and bottom track,
respectively).Additional file 2. The list of single nucleotide variants used for
determination of the parental origin of 16p11.2 and 17q23.2 copynumber
variant deletions.Additional file 3. Distribution of the selected SNVs identified by whole
genome sequencing in the 17q23.1q23.2 copy-number variant (CNV) deletion
region (hg19) showing their enrichment. A) Enrichment of variants
with minor allele frequency (MAF) < 10% (GnomAD, r2.0.2) observed in
the presented patient (AD094). B) Enrichment of variants with MAF < 10%
(GnomAD, r2.0.2) observed in the patient AD094 and previously reported
patients with lethal lung developmental disorder and 17q23.1q23.2 CNV
deletion.Additional file 4. Non-coding single nucleotide variants in the lungspecific
enhancer region, identified in newborns with 17q23.1q23.2 copynumber
variant deletion or TBX4 mutation and lethal lung disease and
absent in the control individuals with the same deletion but without lung
abnormalities.The US National Institutes of Health (NIH),
National Heart Lung and Blood Institute (NHLBI).https://bmcmedgenomics.biomedcentral.comam2020Anatomical PathologyBiochemistryGeneticsMicrobiology and Plant Patholog
Molecular Screening of Keratoconus Susceptibility Sequence Variants in <i>VSX1, TGFBI, DOCK9, STK24</i>, and <i>IPO5</i> Genes in Polish Patients and Novel <i>TGFBI</i> Variant Identification
<p><i>Purpose</i>: Keratoconus (KTCN) is a degenerative disorder of the eye that results in the conical shape and thinning of the cornea and is a leading cause for corneal transplantations. A number of studies suggest that genetic factors play a role in KTCN etiology. Some candidate gene variants have recently been shown to be associated with KTCN. The purpose of our study was to verify the role of <i>VSX1, TGFBI, DOCK9, IPO5</i>, and <i>STK24</i> sequence variants in Polish KTCN patients.</p> <p><i>Methods</i>: Forty-two Polish patients with sporadic KTCN and 50 control individuals were enrolled into this study. Both affected and unaffected individuals underwent detailed ophthalmic examination. The mutations screening in the candidate genes was performed by the direct sequencing method.</p> <p><i>Results</i>: Analysis of <i>VSX1, TGFBI, DOCK9, IPO5</i>, and <i>STK24</i> genes identified numerous sequence variants<i>.</i> Variants c.-264_-255delGGGGTGGGGT, c.627 + 23G > A, c.809-6_809-5insT, and c.*200G > T in the <i>VSX1</i> gene, and heterozygous c.1598G > A mutation (Arg533Gln) in exon 12 of <i>TGFBI</i> were detected for the first time in KTCN patients. Two known sequence variants of <i>TGFBI</i> c.1620T > C (Phe540Phe) and c.1678 + 23G > A were observed in KTCN patients and control individuals. The newly reported c.717 + 43A > G substitution in intron 7 of <i>DOCK9</i> was identified in both KTCN patients and healthy individuals.</p> <p><i>Conclusions</i>: Our investigation showed that KTCN-related sequence variants of analyzed genes were found in a very small proportion of the studied patients indicating that genes other than <i>VSX1, TGFBI, DOCK9, IPO5</i>, and <i>STK24</i> are involved in the development and progression of KTCN in Polish patients. Our results support the hypothesis about the genetic heterogeneity of KTCN.</p
Macrolide and lincosamide resistance of Streptococcus agalactiae in pregnant women in Poland
Abstract Knowing about the antibiotic resistance, serotypes, and virulence-associated genes of Group B Streptococcus for epidemiological and vaccine development is very important. We have determined antimicrobial susceptibility patterns, serotype, and virulence profiles. The antibiotic susceptibility was assessed for a total of 421 Streptococcus agalactiae strains, isolated from pregnant women and neonates. Then, 89 erythromycin and/or clindamycin-resistant strains (82 isolates obtained from pregnant women and seven isolates derived from neonates) were assessed in detail. PCR techniques were used to identify the studied strains, perform serotyping, and assess genes encoding selected virulence factors. Phenotypic and genotypic methods determined the mechanisms of resistance. All tested strains were sensitive to penicillin and levofloxacin. The constitutive MLSB mechanism (78.2%), inducible MLSB mechanism (14.9%), and M phenotype (6.9%) were identified in the macrolide-resistant strains. It was found that macrolide resistance is strongly associated with the presence of the ermB gene and serotype V. FbsA, fbsB, fbsC, scpB, and lmb formed the most recurring pattern of genes among the nine surface proteins whose genes were analysed. A minority (7.9%) of the GBS isolates exhibited resistance to lincosamides and macrolides, or either, including those that comprised the hypervirulent clone ST-17. The representative antibiotic resistance pattern consisted of erythromycin, clindamycin, and tetracycline resistance (71.9%). An increase in the fraction of strains resistant to macrolides and lincosamides indicates the need for monitoring both the susceptibility of these strains and the presence of the ST-17 clone